文献速递临床试验与 GCP

当归须散治疗急性外侧踝关节扭伤的随机对照试验

Effects of Dangguixu-san in patients with acute lateral ankle sprain: a randomized controlled trial.
PubMed 文献 · Trials · 2021-03-04

结果显示两组在VAS评分、FAOS症状/僵硬及疼痛从第1周到第5周的变化存在显著差异,且无不良事件,提示DS联合针灸安全且具有长期镇痛和缓解症状的效果。

要点

  • DS联合针灸在改善疼痛和症状方面优于安慰剂联合针灸。
  • 亚组分析显示II级扭伤患者获益更明显。
  • 两组均未报告不良事件,安全性良好。

核心结论

  • DS联合针灸对I或II级急性外侧踝关节扭伤安全,并在镇痛和缓解症状方面具有积极长期效果。

主要发现

  • VAS评分、FAOS症状/僵硬及FAOS疼痛从第1周到第5周的变化在两组间有显著差异。
  • 亚组分析显示II级扭伤患者中FAOS疼痛(第0周到第5周)以及VAS评分、总FAOS和EQ-5D-5L评分(第1周到第5周)的变化在两组间有显著差异。
  • 两组均无不良事件及临床实验室参数的显著负面变化。

临床怎么用

  • 对于I或II级急性外侧踝关节扭伤,可考虑在针灸基础上联合DS治疗以改善疼痛和症状。

局限性

  • 试验注册为回顾性注册。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Dangguixu-san (DS), a herbal extract, is widely used in Korean medicine to treat pain and swelling caused by ankle sprain. However, there is insufficient evidence regarding the effects of DS on ankle sprains. Accordingly, we assessed the efficacy and safety of DS for the treatment of acute lateral ankle sprain (ALAS). METHODS: This study was a multicenter (two Korean hospitals), randomized, double-blind, placebo-controlled, parallel-arm clinical trial with a 1:1 allocation ratio that included a per-protocol analysis and sub-analysis based on symptom severity. Forty-eight participants (n = 28 at Semyung University Korean Medicine Hospital in Chungju; n = 20 at DongShin University Gwangju Korean Medicine Hospital) with grade I or II ALAS that occurred within 72 h before enrollment were randomized to a DS (n = 24) or placebo (n = 24) group. Both groups received acupuncture treatment once daily for 5 consecutive days and the trial medication (DS/placebo capsule) three times a day for 7 consecutive days. Primary (visual analog scale [VAS] scores for pain) and secondary (Foot and Ankle Outcome Scores [FAOS], edema, and European Quality of Life Five-Dimension-Five-Level Scale [EQ-5D-5L] scores) outcome measures were recorded at baseline (week 0), the end of the intervention (week 1), and 4 weeks after treatment completion (week 5). RESULTS: Forty-six participants completed the trial (n = 23 each). Changes in VAS scores, FAOS Symptom/Rigidity, and FAOS Ache from week 1 to week 5 showed significant differences between the two groups. Sub-analyses showed significant differences in changes of FAOS Ache (week 0 to week 5) and VAS scores, total FAOS, and EQ-5D-5L scores (week 1 to week 5) between the two subgroups (grade II). There were no adverse events and significant negative changes in clinical laboratory parameters in both groups. CONCLUSIONS: Overall, the results of this study are in favor of DS combined with acupuncture and suggest that DS combined with acupuncture is a safe treatment with positive long-term effects in terms of pain reduction and symptom alleviation in patients with grade I or II ALAS. TRIAL REGISTRATION: Clinical Research Information Service KCT0002374 . Registered on July 11, 2017; retrospectively registered.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Kim JH, Lee CK, Lee EY, et al. Effects of Dangguixu-san in patients with acute lateral ankle sprain: a randomized controlled trial. Trials. 2021. PMID: 33663582. doi:10.1186/s13063-021-05135-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。